NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/13/2026
Back to search
Official data from USPTO
GEGANT
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILEDType: WordOffice: United States
Quick snapshot
GEGANT
ST13
US500000079265476Class
5, 10, 42, 44
Filing
79265476
Registration
6039395
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Case type
Application and registration
Recorded events
36
Latest update
08/13/2026
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
06/05/2019
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
739
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Garching, DE
Examiner
BLAZICH, JOAN MICHELE
Current location
Historical data usage
Holders and representatives
Holders
ITM Medical Isotopes GmbH
ITG Isotope Technologies Garching GmbH
Representatives
Kari Moyer-Henry Lewis Kohn & Walker LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Radiopharmaceutical preparations for use in oncologyradiopharmaceuticals containing Gallium-68 for treating and diagnosing tumours; anti-cancer preparationsGallium-68 compoundsincluding 68-Ga chlorides; anti-cancer preparationsGallium-68 for use in the field of targeted radionuclide therapy of cancersin particular prostate cancer and neuroendocrine tumours; cancer diagnostic preparations for medical purposesGallium-68 compoundsincluding 68-Ga peptide chelatesin particular 68-Ga-Dotatoc and 68-Ga-Dotatate68-Ga saltsin particular 68-Ga chlorides; Gallium-68 for use as radiotracers in pet scans or combined PET/CT scans
Class 10
Medical apparatus and instruments for use in positron emission tomography (PET) imagingGe-68/Ga-68 radionuclide generators for pharmaceutical purposes as source of radionuclides being positron emitters in the field of Positron Emission Tomography - Computed Tomography (PET/CT)
Class 42
Scientific and technological services and research on radiopharmaceutical products68-Ga products for use in medicine for third partiesservices relating to radiopharmaceuticals for the therapy and diagnosis of diseases and services relating to radiopharmaceuticals coupled to somatostatin analogues for the diagnosis and treatment of tumoursscientific and product research and development
Class 44
Pharmaceutical advice in relation to radiopharmaceutical products68-Ga products for use in medicine for third partiesadvice in relation to radiopharmaceuticals for the therapy and diagnosis of diseasesin particular tumour diseasespharmaceutical advice in relation to radiopharmaceuticals coupled to somatostatin analogues and advice in relation to the manufacture of personalised radiopharmaceutical products containing 68-Ga for use in medicine
Publications
History of USPTO decisions and trademark events.
36 publications found
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
08/13/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
04/24/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/28/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/08/2020
FIMP
FINAL DISPOSITION PROCESSED
09/04/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/30/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/30/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/30/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/30/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/20/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2019
RFNT
REFUSAL PROCESSED BY IB
10/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/17/2019
RFRR
REFUSAL PROCESSED BY MPU
09/17/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/04/2019
CNRT
NON-FINAL ACTION WRITTEN
09/03/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/03/2019
DOCK
ASSIGNED TO EXAMINER
08/30/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/15/2019
Continuous trademark protection
Get notified about every new filing that threatens GEGANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.